Authors: HEISS MM ALLGAYER H GRUETZNER KU TARABICHI A BABIC R MEMPEL W JAUCH KW SCHILDBERG FW

Citation: Mm. Heiss et al., PROGNOSTIC INFLUENCE OF BLOOD-TRANSFUSION ON MINIMAL RESIDUAL DISEASEIN RESECTED GASTRIC-CANCER PATIENTS, Anticancer research, 17(4A), 1997, pp. 2657-2661

Authors: HEISS MM ALLGAYER H GRUETZNER KU BABIC R JAUCH KW SCHILDBERG FW

Citation: Mm. Heiss et al., CLINICAL-VALUE OF EXTENDED BIOLOGIC STAGING BY BONE-MARROW MICROMETASTASES AND TUMOR-ASSOCIATED PROTEASES IN GASTRIC-CANCER, Annals of surgery, 226(6), 1997, pp. 736-744

Authors: HEISS MM BABIC R ALLGAYER H GRUETZNER KU JAUCH KW LOEHRS U SCHILDBERG FW

Citation: Mm. Heiss et al., THE PROGNOSTIC IMPACT OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR SYSTEM IS ASSOCIATED WITH TUMOR DIFFERENTIATION IN GASTRIC-CANCER, European journal of surgical oncology, 22(1), 1996, pp. 74-77

Authors: HEISS MM ALLGAYER H GRUETZNER KU FUNKE I BABIC R JAUCH KW SCHILDBERG FW

Citation: Mm. Heiss et al., INDIVIDUAL DEVELOPMENT AND UPA-RECEPTOR EXPRESSION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW - A REFERENCE TO EARLY SYSTEMIC-DISEASE IN SOLID CANCER, Nature medicine, 1(10), 1995, pp. 1035-1039

Authors: HEISS MM BABIC R ALLGAYER H GRUETZNER KU JAUCH KW LOEHRS U SCHILDBERG FW

Citation: Mm. Heiss et al., TUMOR-ASSOCIATED PROTEOLYSIS AND PROGNOSIS - NEW FUNCTIONAL RISK-FACTORS IN GASTRIC-CANCER DEFINED BY THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR SYSTEM, Journal of clinical oncology, 13(8), 1995, pp. 2084-2093